228 Pages | 77 Exhibits | 2012 Analysis | Forecasts Through 2016 Product Family: Market Reports

In the medical devices industry, the term "ablation"-primarily referring to radiofrequency or RF ablation-has become a common description attached to devices that "kill or remodel selective tissue without vaporizing the major structures themselves." Today, minimally invasive thermal ablation involves not only RF, but laser, microwave and high-intensity focused ultrasound (HIFU) technologies, and is commonly utilized in several established, growing, technology-driven medical treatment areas, such as benign prostatic hyperplasia (BPH), cancer/tumor ablation, endometrial ablation/menorrhagia, and the treatment of chronic venous insufficiency/varicose veins, as a cost-effective, efficacious alternative to surgery.

In addition to the lucrative (more than $730 million) and steadily growing U.S. thermal ablation medical devices market, nonsurgical energy-based (ablative) aesthetic devices, including laser/light-based and RF-based skin rejuvenation/tightening systems, as well as emerging HIFU and promising new nonsurgical fat reduction technologies such as cryolipolysis, are part of a significantly large, growing market benefiting from an aging population with a high discretionary income and willingness to invest in fast, effective, office-based aesthetic treatments with minimal down time. In 2011, the total estimated U.S. nonsurgical energy-based aesthetic devices market totaled more than $386 million.

Combined, the U.S. thermal ablation devices market-including generators,probes/applicators/instruments/disposables/accessories and service/procedure fees for the treatment areas defined in this report-totaled more than $1.1 billion in 2011. Despite current economic instability, each market segment profiled in this report is expected to increase at moderate to very healthy compound annual growth rates-ranging from 3.3%-17.7%-due to strong demand, cost-efficiency and efficacy, strong reimbursement, emerging unique, proprietary cost-effective, multi-platform next-generation technologies, and an aging population susceptible to various diseases/conditions.

This dynamic report from Medtech Insight includes analyses of products, markets, competitors, and emerging drugs, technology and opportunities. Covered products in this report include selected specialized energy-based generator systems, medical devices/instruments/accessories for the following minimally invasive or nonsurgical ablation treatment areas: BPH, cancer, chronic venous insufficiency/varicose veins, menorrhagia, and selected aesthetic areas, such as skin rejuvenation/skin tightening and body sculpting/cellulite/targeted fat reduction. Other applications include treatment of spinal denervation, stress urinary incontinence, and uterine fibroids.


i. Overview of Thermal Ablation
ii. Thermal Ablation Medical Devices Market
iii. Nonsurgical Energy-Based Aesthetic Devices Market
iv. Methodology

Exhibit ES-1: Thermal Effects on Tissue
Exhibit ES-2: Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016
Exhibit ES-3: Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016
Exhibit ES-4: Nonsurgical Energy-Based Aesthetic Devices, Market Forecast, 2011-2016


1.1 Applications for Thermal Ablation
	1.1.1 Aesthetics-Skin Rejuvenation and Tightening Alma Lasers Cutera Cynosure Palomar Medical Technologies Solta Medical Syneron Medical
	1.1.2 Aesthetics-Body Sculpting, Fat Reduction, and the Reduction in the Appearance of Cellulite Cutera Cynosure Osyris Medical/LSO Medical Solta Medical Syneron Medical Zeltiq Aesthetics
	1.1.3 Benign Prostatic Hyperplasia Transurethral Microwave Thermotherapy American Medical Systems/Endo Health Solutions Boston Scientific ProstaLund Operations Urologix Transurethral Needle Ablation Laser- and Other Energy-Based Therapies Holmium Laser Ablation/Enucleation of the Prostate Lumenis Photoselective Vaporization ofthe Prostate American Medical Systems/Endo Health Solutions
	1.1.4 Cancer/Tumor Ablation Radiofrequency Ablation AngioDynamics Boston Scientific Celsion Covidien Thermedical Other Ablation Methods Cryoablation Sanarus Technologies Microwave Ablation Covidien Microsulis Medical and AngioDynamics High-Intensity Focused Ultrasound EDAP TMS InSightec/Elbit Imaging
	1.1.5 Menorrhagia/Endometrial Ablation Boston Scientific CooperSurgical/The Cooper Companies Ethicon/Johnson & Johnson Hologic
	1.1.6 Spinal Decompression and Denervation ArthroCare Relievant Medsystems Smith & Nephew
	1.1.7 Stress Urinary Incontinence Novasys Medical
	1.1.8 Varicose Vein Ablation AngioDynamics CermaVEIN Covidien
	1.1.9 Uterine Fibroids  InSightec/Elbit Imaging Philips Healthcare/Royal Philips Electronics

Exhibit 1-1: Thermal Effects on Tissue
Exhibit 1-2: The Accent Radiofrequency Platform
Exhibit 1-3: The Pixel CO2 Fractional Laser System and Technology
Exhibit 1-4: The Thermage CPT System
Exhibit 1-5: Sublative and Sublime Skin Rejuvenation Technologies
Exhibit 1-6: The TruSculpt Body Sculpting System
Exhibit 1-7: The Cellulaze Cellulite Laser Workstation
Exhibit 1-8: The Smartlipo LaserBodySculpting Workstations
Exhibit 1-9: The Lipocontrol GPS Laser Assisted Lipolysis System
Exhibit 1-10: A Step-by-Step LipoSonix Procedure
Exhibit 1-11: The VelaShape II System
Exhibit 1-12: The UltraShape Contour I Body Sculpting System
Exhibit 1-13: The CoolSculpting System and Step-by-Step Process
Exhibit 1-14: Advantages and Disadvantages of Minimally Invasive Therapy for Benign Prostatic Hyperplasia
Exhibit 1-15: The CoreTherm System
Exhibit 1-16: Five-Year Clinical Comparison of Symptomatic Reduction in Benign Prostatic Hyperplasia Using the CoreTherm System and Competitive Treatments
Exhibit 1-17: The CoolWave and Targis Systems
Exhibit 1-18: The Cooled ThermCath Advance Catheter
Exhibit 1-19: Cooled ThermoTherapy, Selected Five-Year Clinical Trial Results
Exhibit 1-20: Comparison of Cooled ThermoTherapy with Drug Therapy, Selected Clinical Results
Exhibit 1-21: The Prostiva Radiofrequency Therapy System
Exhibit 1-22: Holmium Laser Ablation of the Prostate Using the VersaPulse PowerSuite Laser System
Exhibit 1-23: Selected Advantages of Holmium Laser Ablation Using the VersaPulse PowerSuite Compared with Photoselective Vaporization Using the GreenLight PV
Exhibit 1-24: The GreenLight High Performance System
Exhibit 1-25: The GreenLight Xcelerated Performance System
Exhibit 1-26: The MoXy Liquid Cooled Fiber
Exhibit 1-27: The Model 1500X Electrosurgical Generator, and StarBurst Xli-Enhanced and Semi-Flex Electrodes
Exhibit 1-28: The StarBurst SDE and MRI Electrodes
Exhibit 1-29: The NanoKnife Low Energy Direct Current System and Electrode Probes
Exhibit 1-30: The RF 3000 Generator and LeVeen Needle Electrode
Exhibit 1-31: The Cool-tip RF Ablation System
Exhibit 1-32: The Cool-tip RF Ablation System E Series
Exhibit 1-33: The HALOFLEX System
Exhibit 1-34: The SERF Ablation System
Exhibit 1-35: The Visica 2 Treatment System and Step-by-Step Cryoablation Process
Exhibit 1-36: The Evident MWA System
Exhibit 1-37: The Acculis MTA System and Three-Step Procedure
Exhibit 1-38: The Ablatherm Robotic HIFU System
Exhibit 1-39: The ExAblate System
Exhibit 1-40: Breast Cancer Treatment Using the ExAblate System
Exhibit 1-41: The Three-Step Endometrial Ablation Process Using  the Genesys HTA System
Exhibit 1-42: The Her Option Cryoablation System
Exhibit 1-43: The Gynecare ThermaChoice III Uterine Balloon Therapy System and a Comparison of Selected Outcome Data with Competitive Thermal Ablation Systems
Exhibit 1-44: The NovaSure System and Step-by-Step Endometrial Ablation Process
Exhibit 1-45: Selected Features of the Next-Generation NovaSure System
Exhibit 1-46: Nucleoplasty Using Coblation Technology
Exhibit 1-47: Intradiscal Electrothermal Therapy and Targeted Disc Decompression
Exhibit 1-48: Renessa Treatment for Stress Urinary Incontinence
Exhibit 1-49: The VenaCure EVLT System
Exhibit 1-50: The SVS System for the Treatment of Varicose Veins
Exhibit 1-51: The Venefit Targeted Endovenous Therapy System
Exhibit 1-52: Endovenous Ablation Using the Venefit System
Exhibit 1-53: Uterine Fibroid Treatment Using the ExAblate System
Exhibit 1-54: Sonalleve Therapy


2.1 Procedure Volumes
2.2 Market Forecast
2.3 Competitive Analysis
	2.3.1 Benign Prostatic Hyperplasia Ablation
	2.3.2 Cancer/Tumor Ablation
	2.3.3 Endometrial Ablation
	2.3.4 Endovenous Ablation
2.4 Other Ablation Markets
	2.4.1 Aesthetics Procedure Volumes Market Forecast Competitive Analysis Nonsurgical Body Sculpting/Fat Reduction
	2.4.2 Spinal Disc Decompression and Denervation

Exhibit 2-1: Thermal Ablation, Procedure Volumes Forecast, by Type, 2011-2016
Exhibit 2-2: Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016
Exhibit 2-3: Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016
Exhibit 2-4: 2011, Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment
Exhibit 2-5: 2016, Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment
Exhibit 2-6: 2011, Benign Prostatic Hyperplasia Laser Ablation Products Market, Share by Supplier
Exhibit 2-7: 2011, Benign Prostatic Hyperplasia Microwave and Radiofrequency Ablation Products Market, Share by Supplier
Exhibit 2-8: 2011, Tumor Ablation Products Market, Share by Supplier
Exhibit 2-9: 2011, Endometrial Ablation Products Market, Share by Supplier
Exhibit 2-10: 2011, Endovenous Ablation Products Market, Share by Supplier
Exhibit 2-11: 2010 and 2011, Selected Aesthetic Procedures and  Average Physician Fees
Exhibit 2-12: 2011, Top 5 Surgical Aesthetic Procedures
Exhibit 2-13: 2011, Top 5 Nonsurgical Aesthetic Procedures
Exhibit 2-14: Selected Nonsurgical Energy-Based Aesthetic Treatments, Procedure Volumes Forecast, 2011-2016
Exhibit 2-15: Nonsurgical Energy-Based Aesthetic Devices, Market Forecast, 2011-2016
Exhibit 2-16: Leading Nonsurgical Energy-Based Aesthetic Device Companies, Global Revenues, 2010-2011
Exhibit 2-17: 2011, Global Nonsurgical Energy-Based Aesthetic Devices Market, Share by Supplier
Exhibit 2-18: 2011, U.S. Nonsurgical Energy-Based Aesthetic Devices Market, Share by Supplier
Exhibit 2-19: 2012, Selected Nonsurgical Energy-Based Body Sculpting/Fat Reduction Systems


3.1 AngioDynamics, Inc.
3.2 Boston Scientific Corporation
3.3 Covidien PLC
3.4 Endo Health Solutions, Inc.
3.5 Hologic, Inc.
3.6 InSightec LTD/Elbit Imaging LTD
3.7 Johnson & Johnson
3.8 Microsulis Medical LTD
3.9 Solta Medical, Inc.
3.10 Syneron Medical LTD
3.11 Zeltiq Aesthetics, Inc.



  1. Alma Lasers LTD
  2. American Medical Systems, Inc./ Endo Health Solutions, Inc.
  3. AngioDynamics, Inc.
  4. ArthroCare Corporation
  5. Boston Scientific Corporation
  6. Celsion Corporation
  7. CermaVEIN S.A.S.
  8. CooperSurgical, Inc./ The Cooper Companies, Inc.
  9. Covidien PLC
  10. Cutera, Inc.
  11. Cynosure, Inc.
  12. EDAP TMS S.A.
  13. Endo Health Solutions, Inc.
  14. Ethicon Endo-Surgery, Inc./ Johnson & Johnson
  15. Ethicon, Inc./ Johnson & Johnson
  16. Hologic, Inc.
  17. InSightec LTD/Elbit Imaging LTD
  18. Johnson & Johnson
  19. Lumenis LTD
  20. Medtronic, Inc.
  21. Microsulis Medical LTD
  22. Novasys Medical, Inc.
  23. Osyris Medical/LSO Medical
  24. Palomar Medical Technologies, Inc.
  25. Philips Healthcare/ Royal Philips Electronics NV
  26. ProstaLund Operations AB
  27. Relievant Medsystems, Inc.
  28. Sanarus Technologies LLC
  29. Smith & Nephew PLC
  30. Solta Medical, Inc.
  31. Syneron Medical LTD
  32. Thermedical, Inc.
  33. Urologix, Inc.
  34. Zeltiq Aesthetics, Inc.
Contact Us

Need help finding medtech research? Let us help you!